Abstract
In order to improve radioimmunotherapy of lymphoma, a Lym-1 single-chain antigen-binding (scFv) protein molecule was produced. Because the commonly used polymerase chain reaction (PCR) method frequently causes unexpected mutations, we developed a non-PCR method for scFv gene assembly. The method involved a stepwise linkage of doubly-restricted DNA fragments and re-digestion of the resultant concatamers. Using this strategy, the Lym-1 scFv expression gene was readily constructed without mutations. The recombinant gene was cloned into an expression vector and scFv protein was expressed. The method can be used for other genes or DNA recombination.
Publication types
-
Research Support, U.S. Gov't, Non-P.H.S.
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Antibodies, Monoclonal / genetics*
-
Antibodies, Monoclonal, Murine-Derived
-
DNA, Recombinant / chemical synthesis*
-
DNA, Recombinant / isolation & purification
-
Deoxyribonuclease EcoRI / pharmacology
-
Deoxyribonucleases, Type II Site-Specific / pharmacology
-
Electrophoresis, Agar Gel
-
Genes, Immunoglobulin
-
Genes, Synthetic*
-
Humans
-
Immunoglobulin Heavy Chains / genetics
-
Immunoglobulin Light Chains / genetics
-
Promoter Regions, Genetic
-
Regulatory Sequences, Nucleic Acid
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Murine-Derived
-
DNA, Recombinant
-
Immunoglobulin Heavy Chains
-
Immunoglobulin Light Chains
-
Lym-1 monoclonal antibody
-
Deoxyribonuclease EcoRI
-
endodeoxyribonuclease DdeI
-
CYCGRG-specific type II deoxyribonucleases
-
Deoxyribonucleases, Type II Site-Specific
-
GCGC-specific type II deoxyribonucleases